Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2017

Dec 27, 2017

31708_dirs_2017-12-27_46aefc4b-625e-44db-b899-9a2babdf608d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2017-12-22

Reporting Person: LeMaitre George W (Director, Chairman and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-22 Common Stock A 5791 $0.00 Acquired 3301299 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-22 Stock Option (Right to Buy) $34.43 A 58261 Acquired 2024-12-22 Common Stock (58261) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 62030 Indirect

Footnotes

F1: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.

F2: These shares are owned by LeMaitre Family LLC. A trust for the benefit of the Reporting Person holds a 20% membership interest in LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by Peter Boland, as trustee for various trusts formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. LeMaitre Family LLC currently holds 310,154 shares of the Issuer's Common Stock. The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

F3: The exercise price of this option to the extent it is an incentive stock option is $34.43 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $31.30 per share.

F4: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary.

F5: The expiration date of this option to the extent it is an incentive stock option is 12/22/2022, and the expiration date of this option to the extent it is a nonqualified stock option is 12/22/2024.